Trials / Completed
CompletedNCT05270980
COVID-19 Serologic Strategies for Skilled Nursing Facilities
COVID-19 Serologic Strategies for Skilled Nursing Facilities (CERO)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 87 (actual)
- Sponsor
- NYU Langone Health · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The COVID-19 pandemic ravaged United States skilled-nursing facilities (SNFs). Novel strategies that maximize the safety and quality of life for SNF residents with ADRD and staff who care for them are urgently needed. Thus, the study's objectives are: 1. To rapidly plan and pilot test an intervention that leverages COVID-19 antibody and PCR status to pair SNF staff with residents in the safest way possible 2. To reduce reduced COVID-19 incidence rate compared to SNFs not using this novel staff-resident assignment strategy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Cohorting | The cohorting strategy will result in "pairing" serology-positive staff with serology-negative residents and serology-negative staff and serology-positive residents to the degree that penetration of serologic presumed immunity allows this pairing to be positive. Any resident who refuses serology testing will be treated as if they are serology negative as the safest strategy for risk of unwanted exposure. |
Timeline
- Start date
- 2021-08-11
- Primary completion
- 2022-02-04
- Completion
- 2022-02-04
- First posted
- 2022-03-08
- Last updated
- 2023-04-06
- Results posted
- 2023-04-06
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT05270980. Inclusion in this directory is not an endorsement.